netCRS: Network-based comorbidity risk score for prediction of myocardial infarction using biobank-scaled PheWAS data
暂无分享,去创建一个
Dokyoon Kim | H. Won | A. Verma | Yonghyun Nam | Sang-Hyuk Jung | Jae-Seung Yun | V. Sriram | J. Yun
[1] Yanwen Chong,et al. Graph-based semi-supervised learning: A review , 2020, Neurocomputing.
[2] M. García-Closas,et al. Combined Utility of 25 Disease and Risk Factor Polygenic Risk Scores for Stratifying Risk of All-Cause Mortality. , 2020, American journal of human genetics.
[3] P. Elliott,et al. Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease. , 2020, JAMA.
[4] Lei Xie,et al. Heterogeneous Multi-Layered Network Model for Omics Data Integration and Analysis , 2020, Frontiers in Genetics.
[5] Ju Han Kim,et al. The translational network for metabolic disease – from protein interaction to disease co-occurrence , 2019, BMC Bioinformatics.
[6] D. Rader,et al. Polygenic Risk Scores for Cardio-renal-metabolic Diseases in the Penn Medicine Biobank , 2019, bioRxiv.
[7] Nicole A. Restrepo,et al. Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia in 106,160 Patients Across Four Health Care Systems. , 2019, The American journal of psychiatry.
[8] M. Feldman,et al. Analysis of polygenic risk score usage and performance in diverse human populations , 2019, Nature Communications.
[9] P. O’Reilly,et al. PRSice-2: Polygenic Risk Score software for biobank-scale data , 2019, GigaScience.
[10] E. Walton,et al. A cross-disorder PRS-pheWAS of 5 major psychiatric disorders in UK Biobank , 2019, bioRxiv.
[11] Alicia R. Martin,et al. Clinical use of current polygenic risk scores may exacerbate health disparities , 2019, Nature Genetics.
[12] Jason E. Miller,et al. Human-Disease Phenotype Map Derived from PheWAS across 38,682 Individuals , 2018, American journal of human genetics.
[13] Joshua C. Denny,et al. Developing and Evaluating Mappings of ICD-10 and ICD-10-CM Codes to Phecodes , 2018, bioRxiv.
[14] Timothy Shin Heng Mak,et al. Tutorial: a guide to performing polygenic risk score analyses , 2018, bioRxiv.
[15] H. Woodrow,et al. : A Review of the , 2018 .
[16] Mary E. Haas,et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.
[17] Stephanie E. Moser,et al. Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative , 2017, bioRxiv.
[18] Lars G Fritsche,et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies , 2017, Nature Genetics.
[19] Sebastian M. Armasu,et al. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2015, Nature Genetics.
[20] Melissa A. Basford,et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data , 2013, Nature Biotechnology.
[21] Marylyn D. Ritchie,et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations , 2010, Bioinform..
[22] B. Starfield,et al. Defining Comorbidity: Implications for Understanding Health and Health Services , 2009, The Annals of Family Medicine.
[23] Krin A. Kay,et al. The implications of human metabolic network topology for disease comorbidity , 2008, Proceedings of the National Academy of Sciences.
[24] A. Barabasi,et al. The human disease network , 2007, Proceedings of the National Academy of Sciences.
[25] M. DePamphilis,et al. HUMAN DISEASE , 1957, The Ulster Medical Journal.